Author(s): Shak JR, Whitaker JA, Ribner BS, Burd EM
Abstract Share this page
Abstract Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.
This article was published in J Clin Microbiol
and referenced in Journal of Aquaculture Research & Development